临床决策支持减少不必要的肝素诱导血小板减少症诊断检测
这项回顾性观察研究评估基于肝素诱导血小板减少症计算机化风险(HIT-CR)评分的临床决策支持(CDS)对减少不必要诊断检测的影响。在20周内,针对预测低风险(HIT-CR评分0-2)患者启动HIT免疫分析医嘱的临床医生,共呈现319次CDS建议,其中80例(25%)诊断检测医嘱被取消,建议的阴性预测值为98.8%(95%CI:97.2-99.5)。基于HIT-CR评分的CDS可减少低验前概率患者的不必要HIT诊断检测。
要点
- 基于HIT-CR评分的CDS在20周内呈现319次建议,80例(25%)免疫分析医嘱被取消。
- 建议的阴性预测值为98.8%(95%CI:97.2-99.5)。
- 139例(44%)患者继续使用肝素产品,264例(83%)未给予替代抗凝治疗。
核心结论
- 基于HIT-CR评分的CDS可减少低验前概率患者的不必要HIT诊断检测。
研究设计与样本
- 回顾性观察研究,评估基于HIT-CR评分的CDS对启动HIT免疫分析医嘱的临床医生的影响。
- CDS向预测低风险(HIT-CR评分0-2)患者的临床医生展示血小板计数-时间图和4Ts评分计算器。
主要发现
- 在20周内,共向启动可能不必要HIT诊断检测的用户呈现319次CDS建议。
- 80例(25%)患者的诊断检测医嘱被取消。
- 139例(44%)患者继续使用肝素产品,264例(83%)患者未给予替代抗凝治疗。
- 建议的阴性预测值为98.8%(95%CI:97.2-99.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Appropriate evaluation of heparin-induced thrombocytopenia (HIT) is imperative because of the potentially life-threatening complications. However, overtesting and overdiagnosis of HIT are common. Our goal was to evaluate the impact of clinical decision support (CDS) based on the HIT computerized-risk (HIT-CR) score, designed to reduce unnecessary diagnostic testing. This retrospective observational study evaluated CDS that presented a platelet count versus time graph and 4Ts score calculator to clinicians who initiated a HIT immunoassay order in patients with predicted low risk (HIT-CR score 0-2). The primary outcome was the proportion of immunoassay orders initiated but cancelled after firing of the CDS advisory. Chart reviews were conducted to assess anticoagulation usage, 4Ts scores and the proportion of patients who had HIT. In a 20-week period, 319 CDS advisories were presented to users who initiated potentially unnecessary HIT diagnostic testing. The diagnostic test order was discontinued in 80 (25%) patients. Heparin products were continued in 139 (44%) patients, and alternative anticoagulation was not given to 264 (83%). The negative predictive value of the advisory was 98.8% (95% CI: 97.2-99.5). HIT-CR score-based CDS can reduce unnecessary diagnostic testing for HIT in patients with a low pretest probability of HIT.
引用
- Gallo T, Curry SC, Heise CW, et al. Clinical decision support to reduce unnecessary diagnostic testing for heparin-induced thrombocytopenia. Br J Haematol. 2023. PMID: 37271143. doi:10.1111/bjh.18902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。